Core Viewpoint - BGM Group Ltd. has completed the acquisition of AIX Inc.'s intelligent platform, marking its entry into AI technology and financial/insurance services, which opens new opportunities for integrated development in healthcare, pharmaceuticals, and insurance on a global scale [1] Group 1: Strategic Importance - The acquisition is a significant milestone for AIX in the AI-driven insurance and healthcare sectors, expected to create unprecedented market opportunities through deep integration of AI technology [2] - BGM views this transaction as a pivotal step in expanding into AI insurance and healthcare sectors, capitalizing on the growing global aging population and increasing healthcare demands [3] Group 2: Market Competitiveness - By acquiring RONS Technology and Xinbao Investment, BGM aims to integrate resources in intelligent technology and biopharmaceuticals, enhancing its competitiveness at the intersection of healthcare and insurance technology [4] - The acquisition allows BGM to leverage its expertise in intelligence technology to enhance digital capabilities, strengthening its position in the evolving pharmaceutical industry [5]
BMG Completed Acquisition of High-Quality Assets, Marking a New Chapter in Diversified Growth